Electrostimulated bone marrow human mesenchymal stem cells produce follistatin

Cytotherapy

Volumn 11, Issue 4, 2009, Pages 448-456

  Genovese, Jorge A ^a,b,c   Spadaccio, Cristiano ^a,c   Rivello, Hernan Garcia ^a   Toyoda, Yoshiya ^a   Patel, Amit N ^a,d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^c Research Unit Dr Negrin University Hospital   (Spain)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Cell differentiation; Cell therapy; Electrostimulation; Follistatin; Mesenchymal stromal cells

Indexed keywords

FOLLISTATIN; TROPONIN I;

ARTICLE; CELL COUNT; CELL DEATH; CELL DENSITY; CELL DIFFERENTIATION; CELL ELONGATION; CELL LOSS; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ELECTROSTIMULATION; FLOW CYTOMETRY; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINDLE CELL; UPREGULATION; WESTERN BLOTTING;

EID: 68049134263     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240902960445     Document Type: Article

References (46)

1. Kogure K, Zhang YQ , Kanzaki M, Omata W, Mine T, Kojima I. Intravenous administration of follistatin: Delivery to the liver and effect on liver regeneration after partial hepatectomy. Hepatology 1996;24:361-6.
2. Ohnishi N, Miyata T, Ohnishi H, Yasuda H, Tamada K, Ueda N et al. Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis. Gut 2003;52:1487-93.
3. Maeshima A, Zhang YQ , Nojima Y, Naruse T, Kojima I. Involvement of the activin-follistatin system in tubular regeneration after renal ischemia in rats. J Am Soc Nephrol 2001;12:1685-95.
4. Aoki F, Kurabayashi M, Hasegawa Y, Kojima I. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. Am J Respir Crit Care Med 2005;172:713-20.
5. Iezzi S, Di Padova M, Serra C, Caretti G, Simone C, Maklan E et al Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev Cell 2004;6:673-84.
6. Harrison CA, Gray PC, Vale WW, Robertson DM. Antagonists of activin signaling: Mechanisms and potential biological applications. Trends Endocrinol Metab 2005;16:73-8.
7. Ueno N, Ling N, Ying SY, Esch F, Shimasaki S, Guillemin R. Isolation and partial characterization of follistatin: A single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci USA 1987;84:8282-6.
8. Sugino K, Kurosawa N, Nakamura T, Takio K, Shimasaki S, Ling N et al. Molecular heterogeneity of follistatin, an activinbinding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell. J Biol Chem 1993;268:15579-87.
9. Ying SY. Inhibins, activins and follistatins. J Steroid Biochem 1989;33:705-13.
10. Kogawa K, Nakamura T, Sugino K, Takio K, Titani K, Sugino H. Activin-binding protein is present in pituitary. Endocrinology 1991;128:1434-40.
11. Shiozaki M, Sakai R, Tabuchi M, Nakamura T, Sugino K, Sugino H, et al Evidence for the participation of endogenous activin A/erythroid differentiation factor in the regulation of erythropoiesis. Proc Natl Acad Sci USA 1992;89:1553-6.
12. Asashima M, Nakano H, Uchiyama H, Sugino H, Nakamura T, Eto Y, et al Presence of activin (erythroid differentiation factor) in unfertilized eggs and blastulae of Xenopus laevis. Proc Natl Acad Sci USA 1991;88:6511-4.
13. Nakamura T, Hasegawa Y, Sugino K, Kogawa K, Titani K, Sugino H. Follistatin inhibits activin-induced differentiation of rat follicular granulosa cells in vitro. Biochim Biophys Acta 1992;1135:103-9.
14. Xiao S, Findlay JK. Interactions between activin and folliclestimulating hormone-suppressing protein and their mechanisms of action on cultured rat granulosa cells. Mol Cell Endocrinol 1991;79:99-107.
15. Aoki F, Kojima I. Therapeutic potential of follistatin to promote tissue regeneration and prevent tissue fibrosis. Endocr J 2007;54:849-54.
16. Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, Conaglen JV, et al. Myostatin, a transforming growth factorbeta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. [iJ Cell Physiol 1999;180:1-9.
17. Morissette MR, Cook SA, Foo S, McKoy G, Ashida N, Novikov M, et al Myostatin regulates cardiomyocyte growth through modulation of Akt signaling. Circ Res 2006;99:15-24.
18. Florholmen G, Halvorsen B, Beraki K, Lyberg T, Sagen EL, Aukrust P, et al. Activin A inhibits organization of sarcomeric proteins in cardiomyocytes induced by leukemia inhibitory factor. J Mol Cell Cardiol 2006;41:689-97.
19. Yndestad A, Ueland T, Oie E, Florholmen G, Halvorsen B, Attramadal H, et al. Elevated levels of activin A in heart failure: Potential role in myocardial remodeling. Circulation 2004;109:1379-85.
20. van den Berg G, Somi S, Buffing AA, Moorman AF, van den Hoff MJ. Patterns of expression of the Follistatin and Follistatinlike1 genes during chicken heart development: A potential role in valvulogenesis and late heart muscle cell formation. Anat Rec (Hoboken) 2007;290:783-7.
21. Adams D, Larman B, Oxburgh L. Developmental expression of mouse Follistatin-like 1 (Fstl1): Dynamic regulation during organogenesis of the kidney and lung. Gene Expr Patterns 2007;7:491-500.
22. Takehara-Kasamatsu Y, Tsuchida K, Nakatani M, Murakami T, Kurisaki A, Hashimoto O, et al. Characterization of follistatinrelated gene as a negative regulatory factor for activin family members during mouse heart development. J Med Invest 2007;54:276-88.
23. Modlin M, Forstner C, Hofer C, Mayr W, Richter W, Carraro U, et al Electrical stimulation of denervated muscles: First results of a clinical study. Artif Organs 2005;29:203-6.
24. Kern H, Salmons S, Mayr W, Rossini K, Carraro U. Recovery of long-term denervated human muscles induced by electrical stimulation. Muscle Nerve 2005;31:98-101.
25. Carraro U, Rossini K, Mayr W, Kern H. Muscle fiber regeneration in human permanent lower motoneuron denervation: Relevance to safety and effectiveness of FES-training, which induces muscle recovery in SCI subjects. Artif Organs 2005;29:187-91.
26. Kuramochi Y, Guo X, Sawyer DB, Lim CC. Rapid electrical stimulation induces early activation of kinase signal transduction pathways and apoptosis in adult rat ventricular myocytes. Exp Physiol 2006;91:773-80.
27. Genovese JA, Spadaccio C, Langer J, Habe J, Jackson J, Patel AN. Electrostimulation induces cardiomyocyte predifferentiation of fibroblasts. Biochem Biophys Res Commun 2008;370:450-5.
28. Genovese JA, Crespi MD, Castro G, Medina FH, Baldi A. Effects of human transforming growth factors on topoisomerases from normal fibroblasts. Life Sci 1988;43:2137-43.
29. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-8.
30. Okamoto K, Miyoshi S, Toyoda M, Hida N, Ikegami Y, Makino H, et al 'Working' cardiomyocytes exhibiting plateau action potentials from human placenta-derived extraembryonic mesodermal cells. Exp Cell Res 2007;313:2550-62.
31. Rucker-Martin C, Pecker F, Godreau D, Hatem SN. Dedifferentiation of atrial myocytes during atrial fibrillation: Role of fibroblast proliferation in vitro. Cardiovasc Res 2002;55:38-52.
32. Cohn RD, Liang HY, Shetty R, Abraham T, Wagner KR. Myostatin does not regulate cardiac hypertrophy or fibrosis. Neuromuscul Disord 2007;17:290-6.
33. Welt C, Sidis Y, Keutmann H, Schneyer A. Activins, inhibins, and follistatins: From endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood) 2002;227:724-52.
34. Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R, et al. Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev Biol 2004;270:19-30.
35. Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 2001;98:9306-11.
36. Wagner KR. Muscle regeneration through myostatin inhibition. Curr Opin Rheumatol 2005;17:720-4.
37. Joulia D, Bernardi H, Garandel V, Rabenoelina F, Vernus B, Cabello G. Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res 2003;286:263-75.
38. Rios R, Carneiro I, Arce VM, Devesa J. Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol 2002;282:C993-9.
39. Taylor WE, Bhasin S, Artaza J, Byhower F, Azam M, Willard DH Jr, et al. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab 2001;280:E221-8.
40. Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, et al. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 2000;275:40235-43.
41. Wagner KR, Liu X, Chang X, Allen RE. Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci USA 2005;102:2519-24.
42. Listrat A, Picard B, Geay Y. Age-related changes and location of type I, III, IV, V and VI collagens during development of four foetal skeletal muscles of double-muscled and normal bovine animals. Tissue Cell 1999;31:17-27.
43. McPherron AC, Lee SJ. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 2002;109:595-601.
44. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997;387:83-90.
45. Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, et al Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004;350:2682-8.
46. Wagner KR, McPherron AC,Winik N, Lee SJ. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol 2002;52:832-6